Dinesh Lodha joins Medikabazaar as new Group CEO

New Delhi: Medikabazaar has appointed Dinesh Lodha as its new Group Chief Executive Officer. With an impressive track record spanning over two decades in the MedTech industry, Lodha is set to steer the company through its next phase of growth and innovation.

Lodha’s appointment aligns with Medikabazaar’s strategic expansion efforts. The healthcare market, valued at approximately USD 11 billion, is experiencing rapid growth, and Medikabazaar is well-positioned, holding around 7% of this market opportunity. Under Lodha’s leadership, the company plans to extend its reach into international markets, including Dubai, Singapore, and China, and explore growth through strategic acquisitions.

In his new role, Lodha expressed, “I am excited to join Medikabazaa. The company is at an inflection point, and I see substantial opportunities across the verticals we operate in. We will continue strengthening our collaborations with leading hospitals and healthcare professionals globally, serving as an extended procurement arm for all their medical procurement.”

Lodha, who has previously held significant roles in both B2B and B2C operations within the FMCG and healthcare sectors, brings valuable experience from his tenure at companies such as Healthium & TI Medical, GE Healthcare, and Samsung. His leadership in transforming supply chain operations and driving profitability is well-recognized, earning him accolades like the Transformational Leader Award from the World Health & Wellness Congress, CEO of the Year from Healthcare Leadership CMO Asia and recognition among the Top 20 Game Changers in Healthcare in India.

A company spokesperson commented, “Dinesh’s proven leadership and track record in the MedTech industry perfectly align with the company’s vision to innovate and expand. His visionary approach and deep understanding of both B2B and B2C operations will undoubtedly propel Medikabazaar to new heights. The team is confident that Dinesh’s leadership will help Medikabazaar to continue to set new benchmarks in the medical procurement space, delivering even greater value to our partners and clients worldwide.”